Gram-positive cocci are responsible for many severe infections in community and hospital settings, and these
multidrug resistant organisms have increased markedly in the past decade. This trend is particularly evident for methicillin/
oxacillin-resistant Staphylococcus aureus (MRSA). MRSA is any strain of Staphylococcus aureus that has developed resistance
to beta-lactam antibiotics, which include the penicillins (methicillin, dicloxacillin, nafcillin, oxacillin, etc.) and the
cephalosporins. S. aureus strains have developed resistance to almost all antibiotics, thereby complicating disease management.
Antibiotics are an essential part of modern medicine and that has helped dramatically in curing patients suffering from
bacterial infections. However, emerging antimicrobial resistance in bacteria threatens to undermine the management of bacterial
infections. A number of factors, which may promote antimicrobial resistance such as availability of antimicrobials without
prescription, suboptimal hygiene, immunosuppression due to malnutrition or HIV, aggressive cancer chemotherapy and an increase
in organ transplantation have resulted in hospitalized patients with immune compromise at high risk of nosocomial infections.
The emergence of antibiotic-resistant mutants among bacteria is seemingly inevitable, that results in the decreased
efficacy and withdrawal of the antibiotic from wide-spread usage. The purpose of this review is to discuss the increase in isolates
of multidrug resistant S. aureus which has created an urgent need for the development of new anti-staphylococcal agents.